netFormulary

North East and North Cumbria
ICS Formulary

4 Central nervous system

04-12 Miscellaneous

Dehydrated alcohol 100% BP for Injection

Formulary

Approved for intrathecal neurolysis treatment of intractable pain due to cancer in terminally ill patients

Eplontersen Wainzua^®

Formulary

45 mg solution for injection in pre-filled pen
Approved as an option for treating hereditary transthyretin-related amyloidosis in adults with stage 1 or stage 2 polyneuropathy in line with NICE

Inotersen Tegsedi^®

Formulary

Approved as an option for treating stage 1 and stage 2 polyneuropathy in adults with hereditary transthyretin amyloidosis in line with NICE

Patisiran Onpattro^®

Formulary

Approved for the treatment of hereditary transthyretin amyloidosis in adults with stage 1 and stage 2 polyneuopathy in line with NICE

Phenol 5% in Glycerol Injection

Formulary

Approved for intrathecal neurolysis treatment of intractable pain due to cancer in terminally ill patients

Tafamidis Vyndaqel^®

Formulary

61 mg soft capsules
Approved for for treating transthyretin amyloidosis with cardiomyopathy in line with NICE

Vutrisiran Amvuttra^®

Formulary

Approved as an option for treating hereditary transthyretin-related amyloidosis in adults with stage 1 or stage 2 polyneuropathy - in line with NICE TA868.
Summer 2023 - Only one centre in London commissioned to provide this drug for patients in England.

Links